225 related articles for article (PubMed ID: 24078696)
1. IL-21 is a double-edged sword in the systemic lupus erythematosus-like disease of BXSB.Yaa mice.
McPhee CG; Bubier JA; Sproule TJ; Park G; Steinbuck MP; Schott WH; Christianson GJ; Morse HC; Roopenian DC
J Immunol; 2013 Nov; 191(9):4581-8. PubMed ID: 24078696
[TBL] [Abstract][Full Text] [Related]
2. A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice.
Bubier JA; Sproule TJ; Foreman O; Spolski R; Shaffer DJ; Morse HC; Leonard WJ; Roopenian DC
Proc Natl Acad Sci U S A; 2009 Feb; 106(5):1518-23. PubMed ID: 19164519
[TBL] [Abstract][Full Text] [Related]
3. Treatment of BXSB-Yaa mice with IL-21R-Fc fusion protein minimally attenuates systemic lupus erythematosus.
Bubier JA; Bennett SM; Sproule TJ; Lyons BL; Olland S; Young DA; Roopenian DC
Ann N Y Acad Sci; 2007 Sep; 1110():590-601. PubMed ID: 17911475
[TBL] [Abstract][Full Text] [Related]
4. CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model.
Nguyen V; Rus H; Chen C; Rus V
J Immunol; 2016 Feb; 196(4):1529-40. PubMed ID: 26792801
[TBL] [Abstract][Full Text] [Related]
5. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice.
Rankin AL; Guay H; Herber D; Bertino SA; Duzanski TA; Carrier Y; Keegan S; Senices M; Stedman N; Ryan M; Bloom L; Medley Q; Collins M; Nickerson-Nutter C; Craft J; Young D; Dunussi-Joannopoulos K
J Immunol; 2012 Feb; 188(4):1656-67. PubMed ID: 22231702
[TBL] [Abstract][Full Text] [Related]
6. IL-21 promotes lupus-like disease in chronic graft-versus-host disease through both CD4 T cell- and B cell-intrinsic mechanisms.
Nguyen V; Luzina I; Rus H; Tegla C; Chen C; Rus V
J Immunol; 2012 Jul; 189(2):1081-93. PubMed ID: 22723520
[TBL] [Abstract][Full Text] [Related]
7. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice.
Jang E; Cho SH; Park H; Paik DJ; Kim JM; Youn J
J Immunol; 2009 Apr; 182(8):4649-56. PubMed ID: 19342640
[TBL] [Abstract][Full Text] [Related]
8. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity.
Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
J Clin Immunol; 2010 Jan; 30(1):45-52. PubMed ID: 19774453
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 6 Accelerates Mortality by Promoting the Progression of the Systemic Lupus Erythematosus-Like Disease of BXSB.Yaa Mice.
Jain S; Park G; Sproule TJ; Christianson GJ; Leeth CM; Wang H; Roopenian DC; Morse HC
PLoS One; 2016; 11(4):e0153059. PubMed ID: 27050763
[TBL] [Abstract][Full Text] [Related]
10. IL-21 is an antitolerogenic cytokine of the late-phase alloimmune response.
Petrelli A; Carvello M; Vergani A; Lee KM; Tezza S; Du M; Kleffel S; Chengwen L; Mfarrej BG; Hwu P; Secchi A; Leonard WJ; Young D; Sayegh MH; Markmann JF; Zajac AJ; Fiorina P
Diabetes; 2011 Dec; 60(12):3223-34. PubMed ID: 22013017
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the antiphospholipid syndrome autoantigen β2 -glycoprotein I potentiates the lupus autoimmune phenotype in a Toll-like receptor 7-mediated murine model.
Giannakopoulos B; Mirarabshahi P; Qi M; Weatherall C; Qi JC; Tanaka K; Millar E; Vonthethoff L; Gatto D; Spielman D; Krilis SA
Arthritis Rheumatol; 2014 Aug; 66(8):2270-80. PubMed ID: 24692206
[TBL] [Abstract][Full Text] [Related]
12. IL-21R expression on CD8+ T cells promotes CD8+ T cell activation in coxsackievirus B3 induced myocarditis.
Liu W; Dienz O; Roberts B; Moussawi M; Rincon M; Huber SA
Exp Mol Pathol; 2012 Jun; 92(3):327-33. PubMed ID: 22465422
[TBL] [Abstract][Full Text] [Related]
13. Key role for IL-21 in experimental autoimmune uveitis.
Wang L; Yu CR; Kim HP; Liao W; Telford WG; Egwuagu CE; Leonard WJ
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9542-7. PubMed ID: 21593413
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of PD-1 and its ligands and expansion of T peripheral helper cells in the nephritic kidneys of lupus-prone BXSB-
Moriyama R; Katsumata Y; Okamoto Y; Harigai M
Lupus; 2024 Jul; 33(8):816-827. PubMed ID: 38622764
[TBL] [Abstract][Full Text] [Related]
16. Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.
Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
Clin Exp Immunol; 2010 Jan; 159(1):11-22. PubMed ID: 19843090
[TBL] [Abstract][Full Text] [Related]
17. Treatment of IL-21R-Fc control autoimmune arthritis via suppression of STAT3 signal pathway mediated regulation of the Th17/Treg balance and plasma B cells.
Ryu JG; Lee J; Kim EK; Seo HB; Park JS; Lee SY; Moon YM; Yoo SH; Park YW; Park SH; Cho ML; Kim HY
Immunol Lett; 2015 Feb; 163(2):143-50. PubMed ID: 25447400
[TBL] [Abstract][Full Text] [Related]
18. Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function.
Ives ML; Ma CS; Palendira U; Chan A; Bustamante J; Boisson-Dupuis S; Arkwright PD; Engelhard D; Averbuch D; Magdorf K; Roesler J; Peake J; Wong M; Adelstein S; Choo S; Smart JM; French MA; Fulcher DA; Cook MC; Picard C; Durandy A; Tsumura M; Kobayashi M; Uzel G; Casanova JL; Tangye SG; Deenick EK
J Allergy Clin Immunol; 2013 Aug; 132(2):400-11.e9. PubMed ID: 23830147
[TBL] [Abstract][Full Text] [Related]
19. B cells from autoimmune BXSB mice are hyporesponsive to signals provided by CD4+ T cells.
Blossom SJ; Gilbert KM
Immunol Invest; 2000 Aug; 29(3):287-97. PubMed ID: 10933611
[TBL] [Abstract][Full Text] [Related]
20. Double-Edged Sword: Interleukin-2 Promotes T Regulatory Cell Differentiation but Also Expands Interleukin-13- and Interferon-γ-Producing CD8
Kato H; Perl A
Front Immunol; 2021; 12():635531. PubMed ID: 33763079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
